IBDEI2FT ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,38933,0)
;;=L03.012^^152^1990^103
;;^UTILITY(U,$J,358.3,38933,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38933,1,3,0)
;;=3^Cellulitis of Left Finger
;;^UTILITY(U,$J,358.3,38933,1,4,0)
;;=4^L03.012
;;^UTILITY(U,$J,358.3,38933,2)
;;=^5009020
;;^UTILITY(U,$J,358.3,38934,0)
;;=L03.021^^152^1990^25
;;^UTILITY(U,$J,358.3,38934,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38934,1,3,0)
;;=3^Acute Lymphangitis of Right Finger
;;^UTILITY(U,$J,358.3,38934,1,4,0)
;;=4^L03.021
;;^UTILITY(U,$J,358.3,38934,2)
;;=^5009022
;;^UTILITY(U,$J,358.3,38935,0)
;;=L03.022^^152^1990^19
;;^UTILITY(U,$J,358.3,38935,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38935,1,3,0)
;;=3^Acute Lymphangitis of Left Finger
;;^UTILITY(U,$J,358.3,38935,1,4,0)
;;=4^L03.022
;;^UTILITY(U,$J,358.3,38935,2)
;;=^5009023
;;^UTILITY(U,$J,358.3,38936,0)
;;=L03.031^^152^1990^113
;;^UTILITY(U,$J,358.3,38936,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38936,1,3,0)
;;=3^Cellulitis of Right Toe
;;^UTILITY(U,$J,358.3,38936,1,4,0)
;;=4^L03.031
;;^UTILITY(U,$J,358.3,38936,2)
;;=^5009025
;;^UTILITY(U,$J,358.3,38937,0)
;;=L03.032^^152^1990^106
;;^UTILITY(U,$J,358.3,38937,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38937,1,3,0)
;;=3^Cellulitis of Left Toe
;;^UTILITY(U,$J,358.3,38937,1,4,0)
;;=4^L03.032
;;^UTILITY(U,$J,358.3,38937,2)
;;=^5009026
;;^UTILITY(U,$J,358.3,38938,0)
;;=L03.041^^152^1990^27
;;^UTILITY(U,$J,358.3,38938,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38938,1,3,0)
;;=3^Acute Lymphangitis of Right Toe
;;^UTILITY(U,$J,358.3,38938,1,4,0)
;;=4^L03.041
;;^UTILITY(U,$J,358.3,38938,2)
;;=^5009028
;;^UTILITY(U,$J,358.3,38939,0)
;;=L03.042^^152^1990^21
;;^UTILITY(U,$J,358.3,38939,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38939,1,3,0)
;;=3^Acute Lymphangitis of Left Toe
;;^UTILITY(U,$J,358.3,38939,1,4,0)
;;=4^L03.042
;;^UTILITY(U,$J,358.3,38939,2)
;;=^5009029
;;^UTILITY(U,$J,358.3,38940,0)
;;=M34.0^^152^1990^289
;;^UTILITY(U,$J,358.3,38940,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38940,1,3,0)
;;=3^Progressive Systemic Sclerosis
;;^UTILITY(U,$J,358.3,38940,1,4,0)
;;=4^M34.0
;;^UTILITY(U,$J,358.3,38940,2)
;;=^5011778
;;^UTILITY(U,$J,358.3,38941,0)
;;=M34.1^^152^1990^92
;;^UTILITY(U,$J,358.3,38941,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38941,1,3,0)
;;=3^CR(E)ST Syndrome
;;^UTILITY(U,$J,358.3,38941,1,4,0)
;;=4^M34.1
;;^UTILITY(U,$J,358.3,38941,2)
;;=^5011779
;;^UTILITY(U,$J,358.3,38942,0)
;;=M34.2^^152^1990^313
;;^UTILITY(U,$J,358.3,38942,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38942,1,3,0)
;;=3^Systemic Sclerosis Induced by Drug/Chemical
;;^UTILITY(U,$J,358.3,38942,1,4,0)
;;=4^M34.2
;;^UTILITY(U,$J,358.3,38942,2)
;;=^5011780
;;^UTILITY(U,$J,358.3,38943,0)
;;=M34.81^^152^1990^315
;;^UTILITY(U,$J,358.3,38943,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38943,1,3,0)
;;=3^Systemic Sclerosis w/ Lung Involvement
;;^UTILITY(U,$J,358.3,38943,1,4,0)
;;=4^M34.81
;;^UTILITY(U,$J,358.3,38943,2)
;;=^5011781
;;^UTILITY(U,$J,358.3,38944,0)
;;=M34.82^^152^1990^316
;;^UTILITY(U,$J,358.3,38944,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,38944,1,3,0)
;;=3^Systemic Sclerosis w/ Myopathy
;;^UTILITY(U,$J,358.3,38944,1,4,0)
;;=4^M34.82
;;^UTILITY(U,$J,358.3,38944,2)
;;=^5011782
;;^UTILITY(U,$J,358.3,38945,0)
;;=M34.83^^152^1990^317
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI2FT 3745 printed Apr 09, 2024@20:51:39 Page 2
IBDEI2FT ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,38933,0)
+2 ;;=L03.012^^152^1990^103
+3 ;;^UTILITY(U,$J,358.3,38933,1,0)
+4 ;;=^358.31IA^4^2
+5 ;;^UTILITY(U,$J,358.3,38933,1,3,0)
+6 ;;=3^Cellulitis of Left Finger
+7 ;;^UTILITY(U,$J,358.3,38933,1,4,0)
+8 ;;=4^L03.012
+9 ;;^UTILITY(U,$J,358.3,38933,2)
+10 ;;=^5009020
+11 ;;^UTILITY(U,$J,358.3,38934,0)
+12 ;;=L03.021^^152^1990^25
+13 ;;^UTILITY(U,$J,358.3,38934,1,0)
+14 ;;=^358.31IA^4^2
+15 ;;^UTILITY(U,$J,358.3,38934,1,3,0)
+16 ;;=3^Acute Lymphangitis of Right Finger
+17 ;;^UTILITY(U,$J,358.3,38934,1,4,0)
+18 ;;=4^L03.021
+19 ;;^UTILITY(U,$J,358.3,38934,2)
+20 ;;=^5009022
+21 ;;^UTILITY(U,$J,358.3,38935,0)
+22 ;;=L03.022^^152^1990^19
+23 ;;^UTILITY(U,$J,358.3,38935,1,0)
+24 ;;=^358.31IA^4^2
+25 ;;^UTILITY(U,$J,358.3,38935,1,3,0)
+26 ;;=3^Acute Lymphangitis of Left Finger
+27 ;;^UTILITY(U,$J,358.3,38935,1,4,0)
+28 ;;=4^L03.022
+29 ;;^UTILITY(U,$J,358.3,38935,2)
+30 ;;=^5009023
+31 ;;^UTILITY(U,$J,358.3,38936,0)
+32 ;;=L03.031^^152^1990^113
+33 ;;^UTILITY(U,$J,358.3,38936,1,0)
+34 ;;=^358.31IA^4^2
+35 ;;^UTILITY(U,$J,358.3,38936,1,3,0)
+36 ;;=3^Cellulitis of Right Toe
+37 ;;^UTILITY(U,$J,358.3,38936,1,4,0)
+38 ;;=4^L03.031
+39 ;;^UTILITY(U,$J,358.3,38936,2)
+40 ;;=^5009025
+41 ;;^UTILITY(U,$J,358.3,38937,0)
+42 ;;=L03.032^^152^1990^106
+43 ;;^UTILITY(U,$J,358.3,38937,1,0)
+44 ;;=^358.31IA^4^2
+45 ;;^UTILITY(U,$J,358.3,38937,1,3,0)
+46 ;;=3^Cellulitis of Left Toe
+47 ;;^UTILITY(U,$J,358.3,38937,1,4,0)
+48 ;;=4^L03.032
+49 ;;^UTILITY(U,$J,358.3,38937,2)
+50 ;;=^5009026
+51 ;;^UTILITY(U,$J,358.3,38938,0)
+52 ;;=L03.041^^152^1990^27
+53 ;;^UTILITY(U,$J,358.3,38938,1,0)
+54 ;;=^358.31IA^4^2
+55 ;;^UTILITY(U,$J,358.3,38938,1,3,0)
+56 ;;=3^Acute Lymphangitis of Right Toe
+57 ;;^UTILITY(U,$J,358.3,38938,1,4,0)
+58 ;;=4^L03.041
+59 ;;^UTILITY(U,$J,358.3,38938,2)
+60 ;;=^5009028
+61 ;;^UTILITY(U,$J,358.3,38939,0)
+62 ;;=L03.042^^152^1990^21
+63 ;;^UTILITY(U,$J,358.3,38939,1,0)
+64 ;;=^358.31IA^4^2
+65 ;;^UTILITY(U,$J,358.3,38939,1,3,0)
+66 ;;=3^Acute Lymphangitis of Left Toe
+67 ;;^UTILITY(U,$J,358.3,38939,1,4,0)
+68 ;;=4^L03.042
+69 ;;^UTILITY(U,$J,358.3,38939,2)
+70 ;;=^5009029
+71 ;;^UTILITY(U,$J,358.3,38940,0)
+72 ;;=M34.0^^152^1990^289
+73 ;;^UTILITY(U,$J,358.3,38940,1,0)
+74 ;;=^358.31IA^4^2
+75 ;;^UTILITY(U,$J,358.3,38940,1,3,0)
+76 ;;=3^Progressive Systemic Sclerosis
+77 ;;^UTILITY(U,$J,358.3,38940,1,4,0)
+78 ;;=4^M34.0
+79 ;;^UTILITY(U,$J,358.3,38940,2)
+80 ;;=^5011778
+81 ;;^UTILITY(U,$J,358.3,38941,0)
+82 ;;=M34.1^^152^1990^92
+83 ;;^UTILITY(U,$J,358.3,38941,1,0)
+84 ;;=^358.31IA^4^2
+85 ;;^UTILITY(U,$J,358.3,38941,1,3,0)
+86 ;;=3^CR(E)ST Syndrome
+87 ;;^UTILITY(U,$J,358.3,38941,1,4,0)
+88 ;;=4^M34.1
+89 ;;^UTILITY(U,$J,358.3,38941,2)
+90 ;;=^5011779
+91 ;;^UTILITY(U,$J,358.3,38942,0)
+92 ;;=M34.2^^152^1990^313
+93 ;;^UTILITY(U,$J,358.3,38942,1,0)
+94 ;;=^358.31IA^4^2
+95 ;;^UTILITY(U,$J,358.3,38942,1,3,0)
+96 ;;=3^Systemic Sclerosis Induced by Drug/Chemical
+97 ;;^UTILITY(U,$J,358.3,38942,1,4,0)
+98 ;;=4^M34.2
+99 ;;^UTILITY(U,$J,358.3,38942,2)
+100 ;;=^5011780
+101 ;;^UTILITY(U,$J,358.3,38943,0)
+102 ;;=M34.81^^152^1990^315
+103 ;;^UTILITY(U,$J,358.3,38943,1,0)
+104 ;;=^358.31IA^4^2
+105 ;;^UTILITY(U,$J,358.3,38943,1,3,0)
+106 ;;=3^Systemic Sclerosis w/ Lung Involvement
+107 ;;^UTILITY(U,$J,358.3,38943,1,4,0)
+108 ;;=4^M34.81
+109 ;;^UTILITY(U,$J,358.3,38943,2)
+110 ;;=^5011781
+111 ;;^UTILITY(U,$J,358.3,38944,0)
+112 ;;=M34.82^^152^1990^316
+113 ;;^UTILITY(U,$J,358.3,38944,1,0)
+114 ;;=^358.31IA^4^2
+115 ;;^UTILITY(U,$J,358.3,38944,1,3,0)
+116 ;;=3^Systemic Sclerosis w/ Myopathy
+117 ;;^UTILITY(U,$J,358.3,38944,1,4,0)
+118 ;;=4^M34.82
+119 ;;^UTILITY(U,$J,358.3,38944,2)
+120 ;;=^5011782
+121 ;;^UTILITY(U,$J,358.3,38945,0)
+122 ;;=M34.83^^152^1990^317
